Lifecore Biomedical, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Lifecore Biomedical, Inc. now
Current reporting with the operating signal separated from the noise.
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q3 2025 Earnings Call Transcript
Investors are testing whether Lifecore Biomedical, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q2 2025 Earnings Call Transcript
Investors are testing whether Lifecore Biomedical, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Lifecore Biomedical, Inc. (LFCR) Q4 2024 Earnings Conference Call Transcript
Investors are testing whether Lifecore Biomedical, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Lifecore Biomedical, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the LFCR Class Action Lawsuit
Investors are testing whether Lifecore Biomedical, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
The story matters when it changes Lifecore Biomedical, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest LFCR filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Lifecore Biomedical, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →